This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

USE OF THE STRONGER SOLUTIONS FOR INSTILLATION

STACY C. HOWELL, M.D.

Arch Ophthal. 1936;16(6):1018-1027.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The value of epinephrine in the treatment of certain types of glaucoma is now well established. That complications may arise from its use is equally well known, and this knowledge creates the necessity of realizing the possibility of such ill effects and understanding them when they occur. Wessely¹ and Darier² were probably the first to demonstrate that the drug lowers intra-ocular pressure. These observations were corroborated both in the laboratory and in the clinic by other investigators.³ Hamburger⁴ has been the most ardent proponent of this form of therapy. It is due chiefly to his tireless efforts and extensive research that the method has become a recognized therapeutic procedure.

When first employed, epinephrine was injected subconjunctivally, usually in doses ranging from 0.3 to 0.5 cc. of a 1: 1,000 solution. When it is realized that such doses represent a relatively large amount of active . . . [Full Text PDF of this Article]

Author Affiliations
ATLANTA, GA.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?